Alizée Lebeau
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Michaël Herfs (4 shared papers)Diane Bruyère (4 shared papers)Pascale Hubert (4 shared papers)Patrick Roncarati (4 shared papers)Coraline Radermecker (1 shared paper)Marie Ancion (3 shared papers)Margot Meunier (1 shared paper)Philippe Delvenne (1 shared paper)
- Journals
- Cellular and Molecular Life Sciences (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)Circulation (1 paper)Cancer Treatment Reviews (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Alizée Lebeau
12 papers receiving 244 citations
Peers
Comparison fields: 5 of 53
- Clinical Biochemistry 37
- Immunology 68
- Oncology 63
- Cancer Research 33
- Molecular Biology 78
Countries citing papers authored by Alizée Lebeau
This map shows the geographic impact of Alizée Lebeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alizée Lebeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alizée Lebeau more than expected).
Fields of papers citing papers by Alizée Lebeau
This network shows the impact of papers produced by Alizée Lebeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alizée Lebeau. The network helps show where Alizée Lebeau may publish in the future.
Co-authors
The 25 scholars most cited alongside Alizée Lebeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 136 | |
| 2 | 2016 | 28 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 17 | |
| 5 | 2023 | 16 | |
| 6 | 2024 | 10 | |
| 7 | 2021 | 7 | |
| 8 | 2023 | 3 | |
| 9 | 2025 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2025 | 2 | |
| 12 | 2025 | 2 |
About Alizée Lebeau
Alizée Lebeau is a scholar working on Oncology, Surgery, Molecular Biology, Epidemiology and Immunology, having authored 12 papers that have together received 245 indexed citations. Recurring topics across this work include Lymphatic System and Diseases (5 papers), Angiogenesis and VEGF in Cancer (2 papers), Cervical Cancer and HPV Research (2 papers), Cancer Cells and Metastasis (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), Hepatitis B Virus Studies (1 paper), Bone Metabolism and Diseases (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Clinical Biochemistry (37 citations), Immunology (68 citations), Oncology (63 citations), Cancer Research (33 citations) and Molecular Biology (78 citations). Alizée Lebeau has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Michaël Herfs, Diane Bruyère, Pascale Hubert, Patrick Roncarati, Coraline Radermecker, Marie Ancion, Margot Meunier, Philippe Delvenne, Olivier Peulen and Stéphanie Demoulin. Their work appears in journals such as Cellular and Molecular Life Sciences, Journal for ImmunoTherapy of Cancer, Circulation, Cancer Treatment Reviews and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.